Effect of the Cervical Interlaminar Epidural Steroid Injection on Quality of Life, Pain and Disability

• Status: Active, not recruiting
• Trial end date: 2020-02-28
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effect of cervical interlaminar epidural steroid injections on the neuropathic pain, quality of life and disability patients with cervical radiculopathy. After the clinical and MRG evaluations of patients with neck and arm pain, injection was given to eligible patients.

Patients undergone the procedure were evaluated before and after injection for neuropathic pain, quality of life and disability.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Marmara University
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Neck pain and / or unilateral arm pain for at least 3 months

• Inadequate response to conservative treatment methods

• Visual analog scale>5

• Treatment of neuropathic pain:

Patients who received adequate treatment for a sufficient period of time (Gabapentine ( ≥4 wk ve ≥ 1200 mg) or Pregabaline ( ≥4 wk ve ≥ 300mg )) and did not respond adequately

Exclusion Criteria:

• Cervical epidural injection history applied in the last 3 months

• Presence of systemic and / or local infection

• Bleeding diathesis

• Pregnancy

• Presence of a history of allergy to contrast agent and local anesthetic agent

• Systemic inflammatory disease ( rheumatoid arthritis, SLE..)

• Presence of malignancy

• Presence of polyneuropathy, multiple sclerosis or demyelinating nervous system diseases

• Patients with a history of surgical operations for cervical disc hernia and / or spinal stenosis

• Patients with myelomalacia due to spinal cord compression